Ai2 is an award-winning company, committed to the development of innovative technology to prevent infection on a wide range of commonly used medical devices like urinary catheters, stents and wound dressings. Their products are proprietary human protein-like substances which safely and cost-effectively inhibit bacteria, fungi and viruses. The treatments are fully compatible with manufacturing methods in this sector. Ai2's humanized cationic peptides are available for exclusive license for many fields, with the primary focus on medical device coatings. However food, media supplement and therapeutic applications are also under development.